Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer

BMC Cancer

Table 1 Clinical data of patients 1369, 2295 and 3133 from whom the cell lines were derived

	Patients
Clinical parameters	1369	2295	3133	112 ¹	1946 ²
Age at diagnosis	58	59	52	42	75
Tumor type	adenocarcinoma	adenocarcinoma	adenocarcinoma	adenocarcinoma	adenocarcinoma
Histopathology sub-type	serous papillary	serous	serous papillary	endometrioid	serous papillary
Tumor grade	G3	G3	G3	G3	G3
Disease stage	IIIC	IIIC	IIIC	IIIC	IIIC
Ascites at surgery	yes	yes	yes	yes	yes
Surgical debulking	sub-optimal	sub-optimal	sub-optimal	sub-optimal	sub-optimal
Progression	yes	yes	yes	yes	yes
Death	yes	yes	yes	yes	yes
Cause of death	disease progression	disease progression	disease progression	disease progression	disease progression
Follow up (months)	28	11	22	1	0.3
Treatment	paclitaxel/carboplatin	cisplatin/topotecan	paclitaxel/carboplatin
	doxorubicin	paclitaxel/carboplatin	doxorubicin
	topotecan	doxorubicin	carboplatin/gemcitabine
Previous history of cancer	breast cancer
Previous chemotherapy	doxorubicine cyclophosphamide docetaxel

¹[13].
²[19] Details pertaining to patients 112 and 1946 are also included, from previous published work.

ISSN: 1471-2407